De Barros André Luís Branco, Mota Luciene Das Graças, Coelho Marina Melo Antunes, Corrêa Natássia Caroline Resende, De Góes Alfredo Miranda, Oliveira Mônica Cristina, Cardoso Valbert Nascimento
J Biomed Nanotechnol. 2015 Feb;11(2):342-50. doi: 10.1166/jbn.2015.1910.
Bombesin (BBN) is a tetradecapeptide that binds specifically to gastrin-releasing peptide receptors in humans. These receptors are over-expressed in several forms of cancer; radiolabeled BBN could therefore be used to detect such cancers. However, the degradation of peptides is a critical issue in the development of tumor tracers. Liposomes can be used to overcome this problem and improve the uptake of tracers by tumors. Therefore, the purpose of this study was to prepare and characterize long-circulating and pH-sensitive liposomes (SpHL) containing 99mTc-HYNIC-βAla-Bombesin(7-14) (99mTc-BBN(7-14). In addition, the ability of this system to identify human breast cancer tissue was evaluated using biodistribution studies and scintigraphic images. Long-circulating and pH-sensitive liposomes (SpHL) were prepared and freeze-dried in the presence of cryoprotectants (glucose, mannitol, and trehalose). They were subsequently reconstituted with a solution of 99mTc-HYNIC-βAla-Bombesin(7-14) (99mTc-BBN(7-14)). The liposomes were evaluated for size, encapsulation percentage, radiotracer leakage, and storage stability. In addition, in vivo studies were performed in breast tumor-bearing nude mice. Liposomes in the presence of glucose (SpHLG), exhibited a mean diameter of 164.5 ± 6.5 nm and exhibited a 99mTc-BBN(7-14) encapsulation percentage of 30%. In addition, they remained highly stable for up to 120 days of storage. SpHLG- 99mTc-BBN(7-14) showed longer blood circulation than free 99mTc-BBN(7-14), did. The tumor-to-muscle and tumor-to-blood ratios for SpHLG-99mTc-BBN(7-14 were high at 4 h post-injection (9.31%ID/g and 7.93%ID/g, respectively). Furthermore, scintigraphic images revealed a strong signal in the tumor area, indicating tumor specificity of SpHLG-99mTc-BBN(7-14). In summary, SpHLG-99mTc-BBN(7-14) presented characteristics suitable for a diagnostic agent, and is a potential tool for tumor identification.
蛙皮素(BBN)是一种十四肽,它能特异性结合人类胃泌素释放肽受体。这些受体在多种癌症中过度表达;因此,放射性标记的BBN可用于检测此类癌症。然而,肽的降解是肿瘤示踪剂开发中的一个关键问题。脂质体可用于克服这一问题,并提高肿瘤对示踪剂的摄取。因此,本研究的目的是制备并表征含有99mTc-HYNIC-β丙氨酸-蛙皮素(7-14)(99mTc-BBN(7-14))的长循环和pH敏感脂质体(SpHL)。此外,通过生物分布研究和闪烁扫描图像评估该系统识别人类乳腺癌组织的能力。制备长循环和pH敏感脂质体(SpHL),并在冷冻保护剂(葡萄糖、甘露醇和海藻糖)存在下冻干。随后用99mTc-HYNIC-β丙氨酸-蛙皮素(7-14)(99mTc-BBN(7-14))溶液将其重构。对脂质体的大小、包封率、放射性示踪剂泄漏和储存稳定性进行了评估。此外,在荷乳腺肿瘤的裸鼠身上进行了体内研究。在葡萄糖存在下的脂质体(SpHLG)平均直径为164.5±6.5nm,99mTc-BBN(7-14)的包封率为30%。此外,它们在储存长达120天时仍保持高度稳定。SpHLG-99mTc-BBN(7-14)的血液循环时间比游离的99mTc-BBN(7-14)更长。注射后4小时,SpHLG-99mTc-BBN(7-14)的肿瘤与肌肉和肿瘤与血液的比率很高(分别为9.31%ID/g和7.93%ID/g)。此外,闪烁扫描图像显示肿瘤区域有强烈信号,表明SpHLG-99mTc-BBN(7-14)具有肿瘤特异性。总之,SpHLG-99mTc-BBN(7-14)具有适合作为诊断剂的特性,是一种潜在的肿瘤识别工具。